Results 241 to 250 of about 995,312 (298)

The T‐Cell Response Mechanism in Human Papillomavirus‐Associated Cervical Cancer and New Strategies for Immunotherapy

iNew Medicine, EarlyView.
ABSTRACT Human papillomavirus (HPV) is a double‐stranded DNA virus that infects human skin and mucosal tissues exclusively. The German scientist Harald zur Hausen was awarded the 2008 Nobel Prize in Physiology or Medicine for his discovery of the link between HPV infection and cervical cancer.
Fang Zhu, Farah Nazir, Ying Zhou, Yuhua Shang, Hongliang He, Tengchuan Jin   +5 more
wiley   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Progesterone Primed Ovarian Stimulation (PPOS) vs. clomiphene Primed Ovarian Stimulation (CPOS) in high responder (HR) patients undergoing controlled ovarian stimulation. A Randomised Control trial. [PDF]

JBRA Assist Reprod
Chaitanya KM, Rao DG, Gambhir I.
europepmc   +1 more source

Lactation, Childrearing, and Gender Justice

Journal of Applied Philosophy, EarlyView.
ABSTRACT In this article, I discuss the significance of early infant feeding choices for the goal of gender justice. Focusing on human lactation practices, I identify Exclusive Gestational Nursing (EGN) as the norm in advanced industrial societies, which creates the expectation and permission for gestators, and only gestators, to nurse children, and ...
Jenny Brown
wiley   +1 more source

Ovarian stimulation toward oocyte cryopreservation for fertility preservation in a patient with Hirata syndrome: a clinical challenge in assisted reproduction. [PDF]

Arch Gynecol Obstet
Karkalemis K, Papadopoulou-Marketou N, Kalampokas E, Simopoulou M, Kalampokas T.   +4 more
europepmc   +1 more source

The role of recombinant LH in ovarian stimulation: what's new? [PDF]

Reprod Biol Endocrinol
Alviggi C, Vigilante L, Cariati F, Conforti A, Humaidan P.   +4 more
europepmc   +1 more source

Impact of COVID-19 infection on laboratory and clinical outcomes of ovarian stimulation using antagonist protocol. [PDF]

Front Med (Lausanne)
Yan Y, Guo M, Chen X, Zhang Q, Wang L, Zhang M, Wang M, Li W, Tao Y.   +8 more
europepmc   +1 more source

Predicting the optimal timing for triggering in controlled ovarian stimulation: mature oocytes retrieval predictor. [PDF]

Reprod Biol Endocrinol
Kobanawa M.
europepmc   +1 more source

Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France. [PDF]

Pharmacoecon Open
Hamamah S, Carette J, Leleu H, Markert M.   +3 more
europepmc   +1 more source

Serum anti-Müllerian hormone and ovarian stimulation parameters in women with polycystic ovary syndrome undergoing assisted reproductive technology: A cross-sectional study. [PDF]

Int J Reprod Biomed
Hosseini S, Salehpour S, Amiresmaili N, Meshkat M, Karimi F.   +4 more
europepmc   +1 more source